WASHINGTON, Oct. 30, 2024 /PRNewswire/ -- LUNGevity Foundation, a nationally recognized nonprofit dedicated to transforming how people are diagnosed and live with lung cancer through research ...

LUNGevity. Although the goal of early detection emerged decades ago, much work remains to be done. Low-dose computed tomography (CT) scanning, used to detect lung cancer, has not changed much in ...

The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung ...

Innovative research brings hope for new approaches to treat RET-positive lung cancer WASHINGTON, Nov. 20, 2024 /PRNewswire/ -- LUNGevity Foundation, the nation's leading lung cancer-focused ...

WASHINGTON, Nov. 20, 2024 /PRNewswire/ -- LUNGevity Foundation, the nation's leading lung cancer-focused nonprofit organization, and RETpositive are honored to announce the recipient of the ...

When you have non-small -lung cancer (NSCLC), the disease and treatments for it can take a toll on how you feel. You may have pain, fatigue, nausea, anxiety, depression, and shortness of breath.

Tissue Biopsies: Tissue collection techniques include bronchoscopy, thoracoscopy, mediastinoscopy, etc. Once the tumor tissue ...

You may experience a high white blood cell count with lung cancer due to infections. Medications, such as chemotherapy, may also affect your white blood cell count. Lung cancer begins with lung ...

AstraZeneca’s IMFINZI ® (durvalumab) has been approved in the US for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed ...